Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3
1997

Glucose Transport Inhibitors and Vincristine Resistance

publication Evidence: moderate

Author Information

Author(s): RL Martell, CA Slapak, SB Levy

Primary Institution: Tufts University School of Medicine and Dana-Farber Cancer Institute

Hypothesis

The study investigates the relationship between glucose transport proteins and multidrug resistance in vincristine-selected murine erythroleukaemia cells.

Conclusion

Glucose transport inhibitors can block vincristine efflux in certain multidrug-resistant cell lines, suggesting a role for glucose transporters in drug resistance.

Supporting Evidence

  • GLUT1 and GLUT3 were co-expressed in the cell lines studied.
  • Glucose transport inhibitors significantly reduced vincristine efflux in the PC-V40 subline.
  • Phloretin and cytochalasin B were effective in blocking vincristine efflux.

Takeaway

The study found that blocking glucose transport can help keep a cancer drug inside cells, which might make the drug work better.

Methodology

The study used murine erythroleukaemia cell lines to measure glucose transport and vincristine accumulation in the presence of glucose transport inhibitors.

Limitations

The study may not fully account for all factors influencing drug resistance in different cell lines.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication